Assessing research gaps and unmet needs in endometriosis - 28/07/19

Abstract |
Endometriosis, a systemic disease that is often painful and chronic, affects ∼10% of reproductive-age women. The disease can have a negative impact on a patient’s physical and emotional well-being, quality of life, and productivity. Endometriosis also places significant economic and social burden on patients, their families, and society as a whole. Despite its high prevalence and cost, endometriosis remains underfunded and underresearched, greatly limiting our understanding of the disease and slowing much-needed innovation in diagnostic and treatment options. Due in part to the societal normalization of women’s pain and stigma around menstrual issues, there is also a lack of disease awareness among patients, health care providers, and the public. The Society for Women’s Health Research convened an interdisciplinary group of expert researchers, clinicians, and patients for a roundtable meeting to review the current state of the science on endometriosis and identify areas of need to improve a woman’s diagnosis, treatment, and access to quality care. Comprehensive and interdisciplinary approaches to disease management and increased education and disease awareness for patients, health care providers, and the public are needed to remove stigma, increase timely and accurate diagnosis and treatment, and allow for new advancements.
Le texte complet de cet article est disponible en PDF.Key words : chronic pain, endometriosis, infertility, pelvic pain, stigma, women’s health
Plan
| This work was supported by a programmatic grant from AbbVie Inc. |
|
| Dr As-Sanie is a consultant to AbbVie Inc and Myovant Sciences and is an author for UpToDate, Inc. Dr Giudice is a consultant to AbbVie Inc, Myovant Sciences, ForEndo, and NextGen Jane. Dr Laufer receives research funding from the Marriott Foundations, is an author for UpToDate, Inc, serves on the International Advisory Board of AbbVie Inc, and is an advisor to NextGen Jane. Dr Missmer serves on advisory boards for AbbVie Inc and Celmatix, is an unfunded collaborator to Oratel Diagnostics, and receives research funding from Marriott Foundations and AbbVie Inc. Dr Norman is author of Ask Me About My Uterus: A Quest to Make Doctors Believe in Women's Pain. Dr Taylor is a consultant to AbbVie Inc and ObsEva. Dr Williams serves as a consultant and is on the speaker’s bureau for AbbVie Inc. The other authors report no conflict of interest. |
Vol 221 - N° 2
P. 86-94 - août 2019 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?
